The AI Boom and the Inevitable Reckoning

Predicting the precise moment of a market reversal is, of course, a fool’s errand. However, the mechanics of this particular bull market offer certain clues as to when the current optimism may begin to fray. To ignore these signals would be to court disaster, a lesson repeatedly taught by market history.

Bitcoin’s Dip & The Usual Suspects

I spent a good hour trying to decipher the accusations, wading through jargon about “halvings” and “redemptions.” It reminded me of those instructional videos for assembling flat-pack furniture, where the presenter speaks in a soothing voice while you’re silently screaming into a pile of particleboard. The gist, as far as I could gather, is that Jane Street is manipulating the market. Or maybe they’re just…trading. It’s hard to tell. My own experience with “manipulation” usually involves trying to convince the barista that, yes, I do deserve a free refill.

NuScale: A Perfectly Reasonable Disaster

Everyone’s talking about nuclear being “hot” again. Fine. Good for them. But NuScale? It’s like they’re actively trying to be the exception. Are we seeing a genuine warning sign, or just a temporary blip? Honestly, who can tell anymore? It’s exhausting.

Echoes in the Digital Steppe

To speak of these assets is to speak of belief, of the narratives we construct around value. The current downturn, a harsh pruning of the overgrowth, forces a reckoning. It is a time for separating the enduring roots from the ephemeral blossoms.

Power Plays & Peculiar Bets

Nuclear Power Plant

BlackRock, bless their sensible hearts, seem to have stumbled upon this rather elementary truth. Artificial intelligence, it appears, is rather power-hungry. Deloitte anticipates a thirty-fold increase in consumption by those data centres. Thirty-fold! One almost feels sorry for the electricity companies, being forced to cater to such gluttony. Almost. So, let’s examine a few companies poised to benefit, or at least, not entirely collapse under the strain.

The Gilded Cage: Yield & Despair

Analysts, those self-proclaimed seers, present their data, their charts, their carefully constructed narratives of past performance. Hartford Funds, in collaboration with Ned Davis Research, have determined that dividend stocks have, over the decades, offered a slightly less agonizing path to ruin than their non-dividend-paying brethren. A mere doubling of returns, they claim, accompanied by a marginally diminished sense of dread. As if numbers could ever truly quantify the human condition. The volatility, they assure us, is lessened. But is a slower descent into oblivion truly preferable to a swift, decisive fall?

Dogecoin: A Calculated Gamble (Don’t Say I Didn’t Warn You)

By mid-2022, it had shed over 90% of its value. A predictable crash, really. It’s currently trading around $0.09. Which, if you’re keeping score, is a long way from its 2021 peak of $0.73. The question is, can it claw its way back? Can it hit a dollar in 2026? Oh, darling, brace yourself. The answer is… complicated. Mostly because it’s likely ‘no,’ and I’m going to enjoy telling you why.

Costco: The Beige Nightmare

It’s a beautiful, terrifying paradox. A retail juggernaut operating on razor-thin margins, fueled by the collective desperation of bargain hunters and bulk-buying fanatics. The membership is the real product, see? A yearly pilgrimage to the altar of consumerism, a tacit agreement to surrender your wallet and your soul. They’re not selling groceries; they’re selling the illusion of savings. And the rubes are lining up for it.

CoreWeave: A Cloud Built on Debt

Let us examine the particulars, not with the breathless optimism of the market’s heralds, but with the dispassionate scrutiny owed to those who place their trust – and their capital – in such ventures.

The Geometry of Loss & Gain

Druckenmiller, a name now echoing with the weight of Buffett’s recent quietude, is a creature of instinct, they say. A gambler who’s merely exchanged the roulette wheel for the relentless calculus of the market. His Duquesne Family Office, a vessel navigating the currents of consequence. The latest reports reveal a shedding, a deliberate winnowing of holdings. Teva Pharmaceutical and Taiwan Semiconductor Manufacturing, once favored blooms in his portfolio, have been pruned. Not from illness, mind you, but from a surfeit of vitality. They had grown too well.